Proton pump inhibitor-induced hypomagnesemia: A new challenge
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Nephrology
- Vol. 1 (6), 151-4
- https://doi.org/10.5527/wjn.v1.i6.151
Abstract
Proton pump inhibitors (PPIs) are commonly used in clinical practice for the prevention and treatment of peptic ulcer, gastritis, esophagitis and gastroesophageal reflux. Hypomagnesemia has recently been recognized as a side effect of PPIs. Low magnesium levels may cause symptoms from several systems, some of which being potentially serious, such as tetany, seizures and arrhythmias. It seems that PPIs affect the gastrointestinal absorption of magnesium. Clinicians should be vigilant in order to timely consider and prevent or reverse hypomagnesemia in patients who take PPIs, especially if they are prone to this electrolyte disorder.Keywords
This publication has 34 references indexed in Scilit:
- Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.2010
- Hypomagnesaemia due to use of proton pump inhibitors--a review.2009
- Physiology of Calcium, Phosphate and MagnesiumEndocrine development, 2009
- Omeprazole and refractory hypomagnesaemiaBMJ, 2008
- Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated diseaseQJM: An International Journal of Medicine, 2008
- TRPM6 and TRPM7—Gatekeepers of human magnesium metabolismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007
- Tetany Secondary to the Use of a Proton-Pump InhibitorAnnals of Internal Medicine, 2002
- Syndrome of Hypokalemic Metabolic Alkalosis and Hypomagnesemia Associated with Gentamicin Therapy: Case ReportsClinical Pediatrics, 2000
- Evaluation of Omeprazole, Lansoprazole, Pantoprazole, and Rabeprazole in the Treatment of Acid-Related DiseasesJournal of the American Pharmaceutical Association, 2000
- Pantoprazole, Prout and the proton pumpHospital Medicine, 1999